What does Solidion Technology do?
Solidion Technology, Inc. is a Nasdaq-listed advanced-battery developer trading under STI. The company is headquartered in Dallas, while its research, development, and manufacturing operations are centered in Dayton, Ohio. Its investor-relations overview describes a business spanning battery materials, components, cells, and selected module or pack technologies. In practical terms, Solidion is trying to solve three persistent battery problems: limited energy density, safety risks from flammable electrolytes, and the cost and manufacturability of silicon-rich or lithium-metal designs.
Which products define the company?
Solidion’s product architecture starts with anode materials and moves downstream into cells. Its portfolio includes graphite-dominant materials, graphene- or elastomer-enhanced silicon and silicon oxide, biochar-derived graphite alternatives, fire-retardant and quasi-solid electrolytes, cylindrical cells, pouch cells, and longer-term lithium-metal or lithium-sulfur concepts. The 2025 Form 10-K reports more than 345 active patents, a 5.5Ah 21700 cylindrical cell with 305 Wh/kg energy density, and silicon or SiOx anode materials with specific capacity ranging from 1,300 to 2,800 mAh/g.
Who are the target customers and applications?
The target customer is not primarily a retail consumer. Solidion is positioning itself as a supplier and development partner to battery-cell manufacturers, electric-vehicle OEMs, energy-storage-system integrators, drone and robotics developers, defense programs, electronics companies, and strategic manufacturing partners. The opportunity is broad, but commercialization depends on converting technical validation into repeatable purchase orders and then supplying at scale.
| Identity item | Current disclosure | Analytical implication |
|---|---|---|
| Listing | Nasdaq Capital Market, ticker STI | Public-market access supports financing, but listing compliance and dilution remain material. |
| Facilities | 27,646 sq. ft. owned building and 7,097 sq. ft. leased building in Dayton, FY2025 | The company owns a technical base but does not yet have mass-production scale. |
| Workforce | 22 full-time employees at December 31, 2025 | Execution is concentrated in a small team and key-person retention matters. |
| Business stage | Minimal product-sample revenue; commercialization and manufacturing buildout ongoing | Technology evidence is ahead of commercial evidence. |
How does Solidion Technology make money?
Solidion’s current accounting model is simple: revenue is recognized when control of products transfers to customers, generally when title, ownership, and risk of loss pass. The strategic model is more layered. Management expects to sell anode materials and battery cells, use toll manufacturers or joint ventures to avoid the full cost of building cell factories immediately, and potentially monetize its patent portfolio through partnerships or licensing structures. Government grants can fund research and validation, but they should not be confused with a mature recurring-revenue engine.
What is the revenue logic today?
Reported sales remain very small. FY2025 net sales were $13,350, and Q1 2026 net sales were $85,426. That means the near-term business is still best understood as commercialization-stage product sampling and early delivery rather than scaled manufacturing. The important signal is not the absolute revenue level; it is whether the company can move from one-off samples to qualified products, recurring customer programs, and economically attractive volume production.
| Revenue pathway | How it works | Current maturity | Margin or cash-flow driver |
|---|---|---|---|
| Anode-material sales | Sell graphite-dominant, SiOx, or silicon-rich materials to cell makers and partners. | Early commercialization | Yield, feedstock cost, customer qualification, and contracted volume. |
| Battery-cell sales | Design and supply cylindrical or pouch cells tailored to application needs. | Prototype and sample stage | Cell performance, toll-manufacturing economics, quality, and warranty risk. |
| TM/JV model | Use toll manufacturing or joint ventures instead of immediately funding a full factory. | Strategic model | Lower initial capex, but less direct control over production and supply chain. |
| IP partnerships | Apply patents to partner products or strategic development programs. | Potential pathway | Royalty terms, enforceability, exclusivity, and partner adoption. |
| Government-funded R&D | Joint research supported by U.S. government grants and laboratories. | Three grants disclosed across Q4 2025 and Q1 2026 | Milestone reimbursement and conversion of research into commercial products. |
How is commercialization supposed to scale?
This sequence is capital-efficient in theory because toll manufacturing can reduce initial factory spending. It also creates dependency: manufacturing quality, yields, delivery schedules, and customer confidence partly sit outside Solidion’s direct control. The business model therefore needs both strong intellectual property and reliable industrial partners.
Which technologies and products matter most?
Why is the silicon-anode platform central?
Silicon can store substantially more lithium than conventional graphite, but expansion during cycling can crack particles, damage the electrode, and reduce useful life. Solidion’s elastomer-protection approach is designed to absorb mechanical stress around silicon particles and electrodes. The company also highlights silane-free and CVD-free routes that could reduce hazardous-gas handling and manufacturing cost. These claims are economically important because a technically superior material that cannot be manufactured safely, consistently, and cheaply will not produce a durable business.
What does the patent portfolio actually protect?
The patent portfolio is broad rather than concentrated in one chemistry. Solidion reports more than 100 key U.S. patents on graphene- or polymer-enhanced silicon materials, more than 35 on fire-resistant electrolytes, and more than 70 on all-solid-state or lithium-metal technologies. Patent expirations generally range from 2028 to 2040. This breadth can create optionality across materials, cells, and safety systems, but it also raises a practical question: which patents can produce enforceable licensing economics or differentiated products before capital is exhausted?
What does Solidion Technology’s latest quarter show?
The latest reported period is the quarter ended March 31, 2026. Solidion’s Q1 2026 Form 10-Q marked its first meaningful quarterly sales disclosure, but the scale remained tiny relative to operating costs and liabilities.
How should the Q1 2026 income statement be read?
| Metric | Q1 2026 | Q1 2025, restated | Interpretation |
|---|---|---|---|
| Net sales | $85,426 | $0 | A commercialization milestone, not yet scale. |
| Gross profit | $83,730 | $0 | Implied gross margin was about 98.0%, but the sample is too small for normalized-margin conclusions. |
| R&D expense | $402,387 | $1,353,050 | Lower spending helped reduce operating loss, but sustained innovation still requires funding. |
| SG&A expense | $1,455,636 | $1,779,619 | Corporate costs remain far larger than revenue. |
| Net loss / income | $(1,430,668) | $9,194,630 | Q1 2025 income was dominated by non-cash derivative gains and was not operating profitability. |
| Operating cash flow | $(141,863) | $(2,342,278) | Reported burn improved, but a $2.04M increase in payables and accruals affected cash conversion. |
What changed versus the FY2025 baseline?
FY2025 results provide a cautionary baseline: net sales of $13,350, operating expenses of $12.93 million, operating loss of $12.92 million, and net loss of $41.00 million. The net loss was heavily affected by a $28.25 million non-cash loss from changes in derivative liabilities, demonstrating why operating loss and cash use are more informative than headline net income for this capital structure.
Which turning points still shape Solidion today?
How did the current company and capital structure emerge?
-
2021Nubia Brand International Corp. was incorporated as a special-purpose acquisition company. This origin matters because the current public-company structure and several financing instruments came through the SPAC pathway rather than a conventional operating-company IPO.
-
March 2022Nubia completed its IPO. The later business combination inherited the public listing, but redemptions and transaction obligations constrained the cash delivered to the operating business.
-
February 2024Nubia merged with Honeycomb Battery Company and was renamed Solidion Technology. Honeycomb became the operating core, bringing battery IP, Dayton facilities, and relationships with Global Graphene Group.
-
2024Solidion completed private placements, expanded patent activity, validated silicon-anode technology, and adopted a Bitcoin treasury policy. The year also created complex warrant and derivative accounting that later required restatement.
-
May–October 2025A 1-for-50 reverse stock split was followed by warrant restructurings, conversions, and a shift in control toward Henry Ikezi-related entities. These actions reduced some derivative overhang but increased ownership concentration and share issuance.
-
Q1 2026Solidion reported $85,426 of quarterly sales, disclosed three U.S. government grants, and signed a non-binding MOU that could represent $4–$6 million of revenue over 12 months if converted into a definitive agreement.
-
June 2026The company raised approximately $34.99 million gross, with about $32 million estimated net proceeds, to fund its Extreme-Climate Battery commercialization, prototypes, inventory, working capital, and customer demand.
What gives Solidion a competitive advantage—and where is the moat unproven?
Which resources could become durable advantages?
The strongest resource is the breadth of the intellectual-property portfolio across silicon anodes, fire-resistant electrolytes, lithium-metal protection, current collectors, and other next-generation chemistries. The second is process compatibility: management argues that its materials and quasi-solid approaches can use existing lithium-ion production equipment, which could shorten time to market relative to entirely new all-solid-state architectures. The third is an asset-light scaling concept using global toll manufacturers, reducing initial factory capex.
Who are the main competitors?
Solidion identifies competition at three levels. In silicon-anode materials, it names Sila Nanotechnologies, Group14, Enovix, Enevate, Nexeon, StoreDot, BTR, Shanshan, and Berzelius. In solid-state or lithium-metal development, it cites QuantumScape, Solid Power, and SES, while describing some as possible partners because Solidion’s protected-anode technologies may be complementary. At the cell level, it competes against manufacturers such as CATL, ATL, LG, Panasonic, Samsung SDI, and Murata, which have far greater capital, manufacturing scale, supply chains, and customer relationships.
| Competitive arena | Named rivals in Solidion filings | Solidion’s proposed differentiation | Unproven element |
|---|---|---|---|
| Silicon anodes | Sila, Group14, Enovix, Enevate, Nexeon, StoreDot and others | Elastomer protection, silane-free routes, broad patent coverage | High-volume yield, qualification time, delivered cost |
| Solid-state / lithium metal | QuantumScape, Solid Power, SES | Process-friendly electrolytes and lithium-metal protection | Cycle life, safety, pressure requirements, mass production |
| Battery cells | CATL, ATL, LG, Panasonic, Samsung SDI, Murata | Specialized high-energy designs and faster customization | Scale, bankability, warranties, long-term supply assurance |
| Graphite alternatives | Conventional synthetic and natural graphite suppliers | Domestic biochar-derived pathway and lower projected emissions | Purity, consistency, customer acceptance, unit economics |
How financially strong is Solidion after the June 2026 financing?
What did the pre-financing balance sheet look like?
At March 31, 2026, Solidion had only $38,887 of cash, $1.36 million of current assets, $13.60 million of liabilities, and an $8.27 million stockholders’ deficit. Short-term notes were $2.61 million, derivative liabilities were $4.21 million, and accounts payable plus accrued expenses were $5.55 million. The company also disclosed default-rate interest of 24% on the EF Hutton note and a 10% rate on the amended Benesch note. Those figures made additional capital essential rather than optional.
| Balance-sheet item | March 31, 2026 | December 31, 2025 | Direction |
|---|---|---|---|
| Cash | $38,887 | $204,725 | Lower by $165,838 |
| Total assets | $5,326,744 | $4,796,854 | Higher, partly from deferred offering costs and other current assets |
| Total liabilities | $13,595,332 | $11,982,428 | Higher |
| Short-term notes | $2,607,666 | $2,647,556 | Slightly lower |
| Derivative liabilities | $4,211,250 | $4,772,600 | Lower from fair-value movements |
| Stockholders’ deficit | $(8,268,588) | $(7,185,574) | Worsened |
How much did the financing change the runway?
The transaction included 750,000 common shares and pre-funded warrants for up to 1,583,000 additional shares, priced at $15.00 per common share or $14.9999 per pre-funded warrant plus a $0.0001 exercise price. The capital materially improves survival capacity and funds Extreme-Climate Battery commercialization, inventory, prototypes, and working capital. It does not eliminate dilution, execution risk, or the need to prove that new spending creates customer revenue.
Who owns Solidion stock, and how does governance matter?
How concentrated is control?
Ownership is highly concentrated. The FY2025 10-K reported Henry Ikezi at 44.5% and Global Graphene Group at 22.5% on a February 9, 2026 basis. A later Schedule 13D/A, summarized in the company’s June 2026 resale prospectus, reported Henry Ikezi and affiliated entities with 3,293,276 shares, or 41.4%, based on an assumed 7,959,720-share denominator. The same filing showed Madison Bond with 2,544,329 shares and Bayside Project with 511,310 shares; these holdings are included within Ikezi’s aggregate beneficial ownership rather than additive independent blocks.
| Holder or group | Shares / stake | Source period | Why it matters |
|---|---|---|---|
| Henry Ikezi and affiliated entities | 3,293,276 shares; 41.4% | Schedule 13D/A, June 11, 2026 basis | Concentrated influence over voting, financing negotiations, and strategic direction. |
| Madison Bond LLC | 2,544,329 shares; 32.0% | Schedule 13D/A basis | Primary vehicle within the Ikezi group and source of bridge liquidity support. |
| Global Graphene Group | 1,744,695 shares; 22.5% | FY2025 10-K, February 9, 2026 basis | Related strategic shareholder and historical source of patents, licenses, and services. |
| Executive officers and directors | 86,370 shares; 1.1% | FY2025 10-K, February 9, 2026 basis | Management’s direct economic stake was small relative to the controlling holders. |
| Common shares outstanding | 8,495,683 | June 10, 2026 | The June 2026 resale prospectus shows the denominator changing after the private placement. |
What governance signals require attention?
Solidion qualifies as a controlled company under Nasdaq standards, allowing exemptions from some governance requirements. The company also disclosed an audit-committee vacancy after a director resigned in September 2025 and postponed its annual meeting to September 15, 2026 in a June 29, 2026 Form 8-K. For minority shareholders, concentrated ownership can support rapid financing and strategic persistence, but it can also reduce the practical influence of outside investors and increase scrutiny of related-party transactions.
What opportunities, risks, and KPIs matter next?
Which opportunities could change the revenue trajectory?
The most concrete opportunity is conversion of customer interest into definitive supply agreements. Solidion disclosed a February 2026 non-binding MOU for pouch cells that could produce an estimated $4–$6 million of revenue over 12 months, although management explicitly warned that it may produce no sales. Other opportunities include U.S. government-funded work on biomass-derived graphite, carbon nanospheres for molten-salt reactors, and fiber batteries with the U.S. Army and the University of Texas at Dallas. Extreme-climate batteries for space, defense, drones, robotics, and AI-infrastructure backup systems broaden the addressable market beyond passenger EVs.
What could weaken the story?
| Risk | Financial or strategic transmission | Evidence to monitor |
|---|---|---|
| Commercialization delay | Revenue remains negligible while R&D, corporate, and qualification costs continue. | Orders, qualified products, production yield, customer concentration. |
| Manufacturing scale-up | Equipment integration, partner dependency, defects, or poor yields can delay delivery and compress margins. | Toll-manufacturing agreements, capacity, scrap, warranty claims. |
| Capital and dilution | New shares and warrants extend runway but reduce ownership per existing share. | Cash burn, share count, new registrations, financing terms. |
| Internal controls and restatement | Accounting errors raise audit costs, reduce confidence, and create filing or listing risk. | Material-weakness remediation and timely SEC filings. |
| Technology competition | Larger rivals may achieve acceptable performance sooner, cheaper, or at larger scale. | Customer awards, independent validation, energy density, cycle life, delivered cost. |
| Related-party and controlled-company exposure | Strategic decisions may be shaped by concentrated holders and affiliated arrangements. | Board independence, related-party balances, voting outcomes. |
| Treasury-strategy distraction | Allocating corporate liquidity to non-operating assets may increase volatility or compete with commercialization needs. | Cash allocation, board approvals, operating runway, treasury disclosures. |
What is the key takeaway from Solidion Technology analysis?
How should a DCF or company-research model treat Solidion?
A conventional mature-company DCF is not appropriate without scenario analysis. Historical revenue is too small to anchor a normal growth curve, gross margin is not normalized, and capital needs have driven repeated share and warrant issuance. A more defensible model separates at least three outcomes: failure to commercialize, limited niche commercialization, and successful scaling through customer contracts and toll manufacturing. Each outcome needs explicit probabilities, timing, revenue ramp, gross margin, R&D intensity, working capital, partner economics, and future dilution.
The June 2026 financing reduces immediate liquidity risk and gives management more capacity to build prototypes, inventory, and customer programs. Yet value creation still depends on milestones outside the balance sheet: definitive contracts, independent technical validation, manufacturable yields, recurring orders, and evidence that customers will pay enough to cover production, warranty, and corporate costs. The company’s official press-release archive is useful for tracking product and patent announcements, while the SEC filing history is essential for testing those announcements against audited financials, contracts, ownership changes, and financing terms.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
